{"id": "-Zo6SmkAAAAJ", "citedby": 5431, "citedby5y": 2511, "hindex": 27, "hindex5y": 19, "i10index": 44, "i10index5y": 27, "coauthors": [], "name": "Philip P. Connell", "affiliation": "Professor of Radiation Oncology, University of Chicago", "interests": ["DNA repair", "pediatric cancers"], "cites_per_year": {"2000": 17, "2001": 39, "2002": 40, "2003": 44, "2004": 56, "2005": 62, "2006": 89, "2007": 53, "2008": 91, "2009": 253, "2010": 271, "2011": 335, "2012": 357, "2013": 414, "2014": 485, "2015": 457, "2016": 503, "2017": 475, "2018": 482, "2019": 444, "2020": 150}, "publications": [{"bib": {"title": "The biology of cancer", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:L8Ckcad2t8MC", "citedby": "2770"}, {"bib": {"title": "Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:JV2RwH3_ST0C", "citedby": "258"}, {"bib": {"title": "Advances in radiotherapy and implications for the next century: a historical perspective", "year": "2009"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:LkGwnXOMwfcC", "citedby": "200"}, {"bib": {"title": "New paradigms and future challenges in radiation oncology: an update of biological targets and technology", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:KlAtU1dfN6UC", "citedby": "140"}, {"bib": {"title": "Significant pelvic recurrence in high-risk pathologic stage I\u2013IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy", "year": "2001"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:2P1L_qKh6hAC", "citedby": "130"}, {"bib": {"title": "RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:RHpTSmoSYBkC", "citedby": "125"}, {"bib": {"title": "Characteristics and outcome of endometrial carcinoma patients age 45 years and younger", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:M3ejUd6NZC8C", "citedby": "117"}, {"bib": {"title": "RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells", "year": "2015"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:M05iB0D1s5AC", "citedby": "102"}, {"bib": {"title": "Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:bEWYMUwI8FkC", "citedby": "102"}, {"bib": {"title": "A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non\u2013small cell lung or esophageal cancer", "year": "2007"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:GnPB-g6toBAC", "citedby": "100"}, {"bib": {"title": "Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers", "year": "2006"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:M3NEmzRMIkIC", "citedby": "90"}, {"bib": {"title": "Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy", "year": "1998"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:kNdYIx-mwKoC", "citedby": "87"}, {"bib": {"title": "The significance of adnexal involvement in endometrial carcinoma", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:r0BpntZqJG4C", "citedby": "86"}, {"bib": {"title": "A chemical compound that stimulates the human homologous recombination protein RAD51", "year": "2008"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:Wp0gIr-vW9MC", "citedby": "83"}, {"bib": {"title": "Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma", "year": "2001"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:d1gkVwhDpl0C", "citedby": "69"}, {"bib": {"title": "DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy", "year": "2014"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:4JMBOYKVnBMC", "citedby": "65"}, {"bib": {"title": "Age as a prognostic factor for recurrence in patients with endometrial carcinoma", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:MXK_kJrjxJIC", "citedby": "65"}, {"bib": {"title": "An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:NaGl4SEjCO4C", "citedby": "64"}, {"bib": {"title": "Synchronous ovarian and endometrial malignancies", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:blknAaTinKkC", "citedby": "61"}, {"bib": {"title": "Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy", "year": "2010"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:hMod-77fHWUC", "citedby": "59"}, {"bib": {"title": "Race and clinical outcome in endometrial carcinoma", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:lSLTfruPkqcC", "citedby": "56"}, {"bib": {"title": "Outcome of endometrial carcinoma patients with involvement of the uterine serosa", "year": "2001"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:YOwf2qJgpHMC", "citedby": "48"}, {"bib": {"title": "Relevance and irrelevance of DNA damage response to radiotherapy", "year": "2004"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:mVmsd5A6BfQC", "citedby": "40"}, {"bib": {"title": "Caution in interpreting biochemical control rates after treatment for prostate cancer: length of follow-up influences results", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:vV6vV6tmYwMC", "citedby": "39"}, {"bib": {"title": "Surgery and postoperative radiation therapy in stage II endometrial carcinoma", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:2osOgNQ5qMEC", "citedby": "33"}, {"bib": {"title": "External pelvic radiation therapy in stage IC endometrial carcinoma", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:IWHjjKOFINEC", "citedby": "30"}, {"bib": {"title": "Tumor size predicts control of benign meningiomas treated with radiotherapy", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ns9cj8rnVeAC", "citedby": "29"}, {"bib": {"title": "Radiotherapy for pediatric brain tumors: when and how", "year": "2007"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:u-x6o8ySG0sC", "citedby": "26"}, {"bib": {"title": "Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience", "year": "2001"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:mB3voiENLucC", "citedby": "25"}, {"bib": {"title": "The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors", "year": "2014"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:qxL8FJ1GzNcC", "citedby": "24"}, {"bib": {"title": "Development of small molecules that specifically inhibit the D-loop activity of RAD51", "year": "2016"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:RYcK_YlVTxYC", "citedby": "22"}, {"bib": {"title": "An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ULOm3_A8WrAC", "citedby": "22"}, {"bib": {"title": "Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:3fE2CSJIrl8C", "citedby": "22"}, {"bib": {"title": "Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer", "year": "2011"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:UeHWp8X0CEIC", "citedby": "20"}, {"bib": {"title": "Recent developments using small molecules to target RAD51: how to best modulate RAD51 for anticancer therapy?", "year": "2016"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:hFOr9nPyWt4C", "citedby": "19"}, {"bib": {"title": "A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal \u2026", "year": "2005"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:qjMakFHDy7sC", "citedby": "18"}, {"bib": {"title": "A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin", "year": "2004"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:HDshCWvjkbEC", "citedby": "17"}, {"bib": {"title": "Real-time solution measurement of RAD51-and RecA-mediated strand assimilation without background annealing", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:HoB7MX3m0LUC", "citedby": "15"}, {"bib": {"title": "The Yin and Yang of treating BRCA-deficient tumors", "year": "2008"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:hqOjcs7Dif8C", "citedby": "14"}, {"bib": {"title": "Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers", "year": "2007"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:isC4tDSrTZIC", "citedby": "14"}, {"bib": {"title": "A downside to apoptosis in cancer therapy?", "year": "2011"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:NMxIlDl6LWMC", "citedby": "12"}, {"bib": {"title": "Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:aqlVkmm33-oC", "citedby": "12"}, {"bib": {"title": "Gene therapy: The challenges of translating laboratory research into clinical practice", "year": "2003"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:5nxA0vEk-isC", "citedby": "11"}, {"bib": {"title": "Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I\u2013II endometrial adenocarcinoma?", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:7PzlFSSx8tAC", "citedby": "11"}, {"bib": {"title": "Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagus", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:_kc_bZDykSQC", "citedby": "9"}, {"bib": {"title": "Maternal embryonic leucine zipper kinase (MELK), A Potential Therapeutic Target for Neuroblastoma", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:TFP_iSt0sucC", "citedby": "8"}, {"bib": {"title": "What is the optimal treatment volume in Hodgkin's disease patients undergoing high\u2010dose chemotherapy and adjuvant radiation therapy?", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:eQOLeE2rZwMC", "citedby": "7"}, {"bib": {"title": "Principles of radiation oncology", "year": "2016"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:IjCSPb-OGe4C", "citedby": "6"}, {"bib": {"title": "Dual and opposite effects of hRAD51 chemical modulation on HIV-1 integration", "year": "2015"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:_FxGoFyzp5QC", "citedby": "5"}, {"bib": {"title": "Optimization of Drug Candidates That Inhibit the D\u2010Loop Activity of RAD51", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ldfaerwXgEUC", "citedby": "4"}, {"bib": {"title": "Low Recombination Proficiency Score (RPS) predicts heightened sensitivity to DNA-damaging chemotherapy in breast cancer", "year": "2017"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:e5wmG9Sq2KIC", "citedby": "4"}, {"bib": {"title": "Small molecule derived from a natural product that mitigates radiation injury", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:_Qo2XoVZTnwC", "citedby": "4"}, {"bib": {"title": "2564: Phase I dose escalation of hypofractionated radiation therapy for patients with oligometastasis", "year": "2006"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:O3NaXMp0MMsC", "citedby": "4"}, {"bib": {"title": "PD-48 Pemetrexed-based concurrent chemoradiotherapy (CRT) for locally advanced or metastatic non-small cell lung or esophageal cancer: A phase I dose-escalating study", "year": "2005"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:k_IJM867U9cC", "citedby": "4"}, {"bib": {"title": "Effect of endoscopic bronchial ultrasound on outcomes for stage I non\u2013small-cell lung cancer patients receiving hypofractionated radiotherapy", "year": "2018"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:WF5omc3nYNoC", "citedby": "3"}, {"bib": {"title": "One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:YFjsv_pBGBYC", "citedby": "3"}, {"bib": {"title": "Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:0EnyYjriUFMC", "citedby": "2"}, {"bib": {"title": "Severe radiation toxicity associated with a germline PTEN mutation", "year": "2017"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:u5HHmVD_uO8C", "citedby": "2"}, {"bib": {"title": "Methods and compositions involving rad51 inhibitors", "year": "2015"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:SeFeTyx0c_EC", "citedby": "2"}, {"bib": {"title": "Methods and compositions for modulating RAD51 and homologous recombination", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:g5m5HwL7SMYC", "citedby": "2"}, {"bib": {"title": "FIGO stage IIIC endometrial cancer patients undergoing surgery and adjuvant radiation therapy", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:Y0pCki6q_DkC", "citedby": "2"}, {"bib": {"title": "Pelvic recurrence in high-risk pathologic stage I\u2013IV endometrial carcinoma patients following adjuvant chemotherapy alone: Implications for locoregional radiation therapy", "year": "2000"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:9yKSN-GCB0IC", "citedby": "2"}, {"bib": {"title": "Impact of cardiac dose on cardiac events and survival in unresectable lung cancer patients", "year": "2017"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ufrVoPGSRksC", "citedby": "1"}, {"bib": {"title": "Strategies to overcome late complications from radiotherapy for childhood head and neck cancers", "year": "2016"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:BqipwSGYUEgC", "citedby": "1"}, {"bib": {"title": "Methods and compositions for modulating RAD51 and homologous recombination", "year": "2015"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:70eg2SAEIzsC", "citedby": "1"}, {"bib": {"title": "An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:3s1wT3WcHBgC", "citedby": "1"}, {"bib": {"title": "2162 One versus two low-dose-rate intracavitary brachytherapy treatments in early stage cervical cancer treated with radiation therapy alone", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:R3hNpaxXUhUC", "citedby": "1"}, {"bib": {"title": "Prognostic factors and patterns of failure in pathologic stage II endometrial cancer", "year": "1997"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:UebtZRa9Y70C", "citedby": "1"}, {"bib": {"title": "Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:maZDTaKrznsC", "citedby": "0"}, {"bib": {"title": "Radiation-Induced Sarcoma After Heterotopic Ossification Prophylaxis: A Case Report", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:Tyk-4Ss8FVUC", "citedby": "0"}, {"bib": {"title": "Small molecules inhibitors of rad51", "year": "2019"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:iH-uZ7U-co4C", "citedby": "0"}, {"bib": {"title": "Retuning the Radio in Radiobiology", "year": "2018"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:YsMSGLbcyi4C", "citedby": "0"}, {"bib": {"title": "Abstract PR02: Small molecules that specifically inhibit the D-loop activity of RAD51", "year": "2017"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ZeXyd9-uunAC", "citedby": "0"}, {"bib": {"title": "Methods and compositions relating to cancer therapy with dna damaging agents", "year": "2016"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:J_g5lzvAfSwC", "citedby": "0"}, {"bib": {"title": "Low Recombination Proficiency Score (RPS) in Breast Cancer Predicts Malignant Potential and Heightened Sensitivity to DNA-damaging Therapies", "year": "2015"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:ZHo1McVdvXMC", "citedby": "0"}, {"bib": {"title": "Repair Pathway Score (RPS) Predicts DNA Repair Pathway Preference and Cancer Patient Outcome", "year": "2013"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:Zph67rFs4hoC", "citedby": "0"}, {"bib": {"title": "A High Throughput Cell-based Screen Identifies Compounds That Inhibit the Viral Oncoprotein E6 in Human Papillomavirus-positive Cancers", "year": "2012"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Identification of a Chemical Inhibitor of RAD51 that Disrupatients Homologous Recombinational DNA Repair in Human Cells", "year": "2011"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:Se3iqnhoufwC", "citedby": "0"}, {"bib": {"title": "Concurrent Chemoradiotherapy followed by Surgery for Locally Advanced Esophageal Cancer: The University of Chicago Experience", "year": "2010"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:pqnbT2bcN3wC", "citedby": "0"}, {"bib": {"title": "High Necrosis Rates and Excellent Outcomes in Locally Advanced Sarcomas Treated with Pre-operative Hypofractionated Radiotherapy and Concurrent Chemotherapy", "year": "2008"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:4DMP91E08xMC", "citedby": "0"}, {"bib": {"title": "Identification of a Small Moleculue That Stimulates Human RAD51 Protein", "year": "2007"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:35N4QoGY0k4C", "citedby": "0"}, {"bib": {"title": "Stage IIIA Non-Small Cell Lung Cancers Treated with Neoadjuvant Concurrent Chemotherapy and High Dose Radiotherapy Followed by Resection", "year": "2005"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:QIV2ME_5wuYC", "citedby": "0"}, {"bib": {"title": "Inhibitors of XRCC3p", "year": "2003"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:roLk4NBRz8UC", "citedby": "0"}, {"bib": {"title": "Is whole abdominal radiation therapy (wart) indicated in FIGO stage IIIA endometrial adenocarcinoma patients with isolated involvement of the uterine serosa", "year": "2001"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:zYLM7Y9cAGgC", "citedby": "0"}, {"bib": {"title": "An analysis of the impact of adjuvant chemotherapy for invasive carcinoma of the esophagus", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:4TOpqqG69KYC", "citedby": "0"}, {"bib": {"title": "Length of follow-up influences biochemical control rates after treatment for prostate cancer", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "2137 Clinical and biochemical outcome following conformal radiotherapy for prostate cancer: A focus on racial differences", "year": "1999"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "Significance of tumor size in incompletely resected benign meningiomas undergoing radiation therapy", "year": "1998"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Prognostic significance of race in endometrial carcinoma", "year": "1998"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:dhFuZR0502QC", "citedby": "0"}, {"bib": {"title": "Vaginal brachytherapy is not necessary in stage ic endometrial carcinoma patients treated with surgery and postoperative whole pelvic radiation", "year": "1998"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:9ZlFYXVOiuMC", "citedby": "0"}, {"bib": {"title": "Risk groups in pathologic stage III endometrial carcinoma", "year": "1997"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:j3f4tGmQtD8C", "citedby": "0"}, {"bib": {"title": "2016 Annual Meeting Abstract Award Recipients"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:RGFaLdJalmkC", "citedby": "0"}, {"bib": {"title": "Comparative Survival in Patients with Postresection Recurrent Versus Newly Diagnosed Non\u2013Small-Cell Lung Cancer Treated with Radiotherapy Page 1100 X.-W. Cai, L.-Y. Xu, L. Wang \u2026"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:8k81kl-MbHgC", "citedby": "0"}, {"bib": {"title": "Index by Topic"}, "source": "citations", "id_citations": "-Zo6SmkAAAAJ:W7OEmFMy1HYC", "citedby": "0"}]}